Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
Press ReleaseCardiawave Announces Positive 12-Month Results from Its “Valvosoft® FIM Study” and “Valvosoft® Pivotal Study”, presented at EuroPCR! May 23, 2025 READ MORE
EventsCardiawave contribue à l’écosystème dynamique de l’excellence française dans les ultrasons médicaux May 20, 2025 READ MORE
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
